These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15847132)

  • 1. The use of drug-eluting stents in everyday clinical practice: can the results of randomised trials be achieved in the "real world"?
    Sionis DG
    Hellenic J Cardiol; 2005; 46(2):124-7. PubMed ID: 15847132
    [No Abstract]   [Full Text] [Related]  

  • 2. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
    Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
    Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender medicine and drug eluting coronary stents.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):814-6. PubMed ID: 21104730
    [No Abstract]   [Full Text] [Related]  

  • 5. Forget Mars and venus, men and women are from the same planet after all.
    Parikh PB; Gruberg L
    J Invasive Cardiol; 2012 Jun; 24(6):261-2. PubMed ID: 22684378
    [No Abstract]   [Full Text] [Related]  

  • 6. A cagey proposition.
    Ho YD; Lee DP
    J Invasive Cardiol; 2008 Jan; 20(1):28. PubMed ID: 18174615
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug for a while, polymer for life: Is it a good solution?
    Kastrati A
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):340-1. PubMed ID: 18288754
    [No Abstract]   [Full Text] [Related]  

  • 8. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Stettler C; Sangiorgi D; D'Ascenzo F; Kimura T; Briguori C; Sabatè M; Kim HS; De Waha A; Kedhi E; Smits PC; Kaiser C; Sardella G; Marullo A; Kirtane AJ; Leon MB; Stone GW
    Lancet; 2012 Apr; 379(9824):1393-402. PubMed ID: 22445239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus.
    Ali RM; Degenhardt R; Zambahari R; Tresukosol D; Ahmad WA; Kamar Hb; Kui-Hian S; Ong TK; bin Ismail O; bin Elis S; Udychalerm W; Ackermann H; Boxberger M; Unverdorben M
    EuroIntervention; 2011 May; 7 Suppl K():K83-92. PubMed ID: 22027736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVUS guidance results in lower in-stent restenosis: A chapter for a history book?
    Colombo A
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):322-3. PubMed ID: 12822149
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-coated balloon after coronary stenting falls short.
    Belardi JA; Albertal M
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):332-3. PubMed ID: 25045099
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary stents reduce restenosis and repeat revascularizations and may also improve survival.
    Vik-Mo H; Bønaa KH
    Scand Cardiovasc J; 2004 Aug; 38(4):195-6. PubMed ID: 15553928
    [No Abstract]   [Full Text] [Related]  

  • 14. The drug-eluting stent: is it the Holy Grail?
    Hiatt BL; Carter AJ; Yeung AC
    Rev Cardiovasc Med; 2001; 2(4):190-6. PubMed ID: 12439368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents. The third revolution in percutaneous coronary intervention.
    Saia F; Marzocchi A; Serruys PW
    Ital Heart J; 2005 Apr; 6(4):289-303. PubMed ID: 15902927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.
    Nakazawa G; Finn AV; Vorpahl M; Ladich ER; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2011 Jan; 57(4):390-8. PubMed ID: 21251578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
    Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
    Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. Results of TAXUS IV].
    Liakishev AA
    Kardiologiia; 2004; 44(3):77. PubMed ID: 15489834
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of drug-eluting stents: if only all things were equal.
    Chew DP
    Med J Aust; 2005 Apr; 182(8):376-7. PubMed ID: 15850431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.